Literature DB >> 10336025

Optical sector iridectomy in corneal opacities.

R B Vajpayee1, N Sharma, T Dada, N Pushker.   

Abstract

PURPOSE: To evaluate the visual outcome after optical sector iridectomy in cases of corneal opacities.
METHODS: Seventeen eyes of 17 patients with preoperative visual acuity of <6/60 in the affected eye underwent sector iridectomy in a prospective clinical study at a tertiary eye care center. Of 17 cases, 11 had corneal opacities after healed keratitis, four after trauma, and one each due to alkali burns or trachoma. The sector iridectomy was undertaken in cases in which one sector of the cornea and lens was fairly clear. Success was defined as attainment of ambulatory visual acuity of 6/60 or better.
RESULTS: Mean age of the patients was 32+/-2.3 years. Most eyes had deep vascularized corneal scars (13 eyes). Optical sector iridectomy was performed most frequently in the lower nasal quadrant (11 eyes) followed by the lower temporal quadrant (four eyes). Of 17 eyes, 16 achieved a visual acuity of 6/60 or better. No intra-or postoperative complications were encountered.
CONCLUSION: Optical sector iridectomy in cases of corneal opacities is a simple and safe procedure that can improve visual outcome and provide ambulatory vision to patients. It is a valuable alternative to penetrating keratoplasty if penetrating keratoplasty is not possible or not promising for various reasons.

Entities:  

Mesh:

Year:  1999        PMID: 10336025     DOI: 10.1097/00003226-199905000-00003

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  2 in total

1.  Outcome of optical iridectomy in Peters anomaly.

Authors:  Oriel Spierer; Kara M Cavuoto; Sirinya Suwannaraj; Craig A McKeown; Ta Chen Chang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-04-28       Impact factor: 3.117

2.  Visual outcome of cataract surgery with pupillary sphincterotomy in eyes with coexisting corneal opacity.

Authors:  Rajesh Sinha; Namrata Sharma; Rasik B Vajpayee
Journal:  BMC Med       Date:  2004-04-07       Impact factor: 8.775

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.